CG
CYTK icon

Cutler Group’s Cytokinetics CYTK Stock Holding History

Cutler Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$42K Buy
+603
New +$46.6K 0.01% 746
2023
Q4 		– Sell
-2,500
Closed -$90.5K – 3725
2023
Q3 		$73K Buy
+2,500
New +$83.3K 0.01% 1289
2023
Q1 		– Sell
-10
Closed -$408 – 3942
2022
Q4 		$0 Buy
+10
New +$430 ﹤0.01% 4533
2022
Q2 		– Sell
-1,664
Closed -$67K – 5079
2022
Q1 		$61K Sell
1,664
-270
-14% -$9.59K ﹤0.01% 2089
2021
Q4 		$88K Buy
1,934
+1,923
+17,482% +$74.2K ﹤0.01% 1941
2021
Q3 		$0 Sell
11
-489
-98% -$14.4K ﹤0.01% 5803
2021
Q2 		$9K Sell
500
-100
-17% -$2.35K ﹤0.01% 3968
2021
Q1 		$13K Sell
600
-6,900
-92% -$147K ﹤0.01% 3559
2020
Q4 		$155K Sell
7,500
-500
-6% -$9.14K 0.01% 1236
2020
Q3 		$173K Buy
+8,000
New +$187K 0.01% 995
2019
Q1 		– Sell
-8,500
Closed -$53K – 4143
2018
Q4 		$53K Buy
+8,500
New +$62.4K 0.01% 1440
2018
Q3 		– Sell
-100
Closed – – 4188
2018
Q2 		$0 Sell
100
-1,200
-92% -$9.99K ﹤0.01% 4305
2018
Q1 		$9K Sell
1,300
-2,800
-68% -$24K ﹤0.01% 2849
2017
Q4 		$33K Sell
4,100
-6,081
-60% -$69K ﹤0.01% 2176
2017
Q3 		$147K Buy
10,181
+6,163
+153% +$84.2K 0.01% 1378
2017
Q2 		$48K Sell
4,018
-11,434
-74% -$159K ﹤0.01% 2536
2017
Q1 		$198K Sell
15,452
-27,900
-64% -$326K 0.01% 1203
2016
Q4 		$526K Buy
43,352
+20,913
+93% +$222K 0.02% 666
2016
Q3 		$205K Buy
22,439
+14,909
+198% +$156K 0.01% 1183
2016
Q2 		$71K Sell
7,530
-106
-1% -$870 ﹤0.01% 2005
2016
Q1 		$53K Buy
7,636
+1,897
+33% +$13.9K ﹤0.01% 2266
2015
Q4 		$60K Buy
+5,739
New +$56.3K ﹤0.01% 2264

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Cutler Group's CYTK Position: Q1 2024 in Review

Cutler Group opened a new position in Cytokinetics (CYTK) in Q1 2024: 603 shares worth $42K. The stake represents 0.01% of the portfolio and ranks #746 among its holdings. This is a return to the name: Cutler Group previously reported a position in CYTK as recently as Q3 2023.

Cutler Group first reported a position in CYTK in Q4 2015 and has held it in 22 quarters since. The position peaked at $526K in Q4 2016. 390 funds tracked by Wall St. Rank hold CYTK as of Q1 2024.

  • Cutler Group held 603 shares of Cytokinetics worth $42K as of Q1 2024.
  • Cytokinetics was a new Cutler Group position in Q1 2024.
  • Cytokinetics made up 0.01% of Cutler Group's portfolio in Q1 2024, its #746 holding.
  • Cutler Group first reported a position in Cytokinetics in Q4 2015 and has held it in 22 quarters since.
  • Cutler Group's Cytokinetics position peaked at $526K in Q4 2016.
  • 390 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.